NR0B1 / Nuclear receptor subfamily 0 group B member 1 · Western blot design guide

Design a Western Blot for NR0B1

Source-linked NR0B1 Western blot protocol options, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-NR0B1 WB antibodies. Everything you need to plan the experiment before you commit precious samples.

Evidence assembled September 2026 · For research use; verify linked source records and product datasheet before use
Western blot protocol sheet for NR0B1: expected band ~51.7 kDa, hero antibody A01521-2, catalog values and labelled standard workflow; separate PMC comparisons on the guide
Printable NR0B1 Western blot protocol sheet — expected band ~51.7 kDa, antibody A01521-2, controls and PMC citations. Open the full NR0B1 WB guide →

NR0B1 Western Blot Experimental Design Guide

Expected bands, source-linked protocol options, controls and antibodies — the at-a-glance facts below, then the full design guide.

Must know before running
Expected band ~51.7 kDa
Observed band ~48 kDa
Gel 5–20% (catalog A01521-2)
Negative control ⓘ Suggested KO / knockdown lysate
Important caveats
Reasons your observed band may differ from the expected size.
PTM —
Caveat —
Gene-set association MSigDB C7 membership
Isoform 2 isoform(s)
Section 1

Source-Linked NR0B1 Western Blot Protocol Options

The A01521-2 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.

Recommended Western blot protocol parameters
Sample / lysatehuman MCF-7, human Hela, human Jurkat, human U87 (catalog A01521-2)
Gel %5–20% (catalog A01521-2)
Load30 ug; reducing conditions (catalog A01521-2)
Transfera nitrocellulose membrane at 150 mA for 50-90 minutes (catalog A01521-2)
Membranenitrocellulose membrane (catalog A01521-2)
Blocking5% non-fat milk/TBS for 1.5 hour at RT (catalog A01521-2)
Primary antibodyA01521-2 · 0.5 μg/mL (catalog A01521-2)
Primary incubationovernight at 4°C (catalog A01521-2)
Secondary antibodygoat anti-rabbit IgG-HRP, 1:5000 (catalog A01521-2)
Secondary incubation1.5 hour at RT (catalog A01521-2)
WashTBS-0.1%Tween 3 times with 5 minutes each (catalog A01521-2)
DetectionECL (catalog A01521-2)
Section 2

What Is the Expected NR0B1 Western Blot Band Size?

NR0B1 is predicted at 51.7 kDa and observed near 48 kDa; the cause of the difference is not established.

What am I looking at on my blot?
Band near 48 kDaEmpirical NR0B1 band in reducing whole-cell lysates; confirm identity with controls
Band near 51.7 kDaNear the predicted protein mass; identity requires confirmation
Higher band near twice the monomer sizeCould reflect an NR0B1 homodimer if it survives sample preparation
Multiple bands at different sizesCould reflect isoforms 1 and 2, but their migration is not established
Weak band in one cell fractionNR0B1 shuttles between nucleus and cytoplasm
💡Expected NR0B1 appearanceNR0B1 has a predicted mass of 51.7 kDa, while antibody QC shows a band near 48 kDa in reducing whole-cell lysates; confirm band identity with appropriate controls.
How each factor affects band size
Predicted NR0B1 mass51.7 kDa by sequence, versus the empirical band near 48 kDa; the difference is unexplained
Splice isoform 1May differ in size from isoform 2; its mass and migration are unspecified
Splice isoform 2May differ in size from isoform 1; its mass and migration are unspecified
NR0B1 homodimerCould appear near twice the monomer size if it remains intact during electrophoresis
Why is my band missing or off?
SituationLikely causeNext action
No band in lysateNR0B1 may be poorly recovered from the nuclear fractionCheck nuclear extraction and include a positive lysate control
Band higher than expectedAn NR0B1 homodimer may persist during sample preparationCompare reducing and nonreducing samples and confirm band identity
Band lower than expectedThe observed 48 kDa band is below the 51.7 kDa prediction for an unestablished reasonCompare with a positive control and verify antibody specificity
Multiple bandsIsoforms 1 and 2 are documented, but distinct bands are not establishedUse isoform-aware controls to assign bands
Weak or no signalNR0B1 may partition between nucleus and cytoplasmCheck both fractions and include a positive lysate control

Sample controls for NR0B1 Western blot

🧪For positive controls for NR0B1 in Western blot, you can use an independently validated NR0B1-positive lysate; the supplied HPA evidence identifies no positive tissue or cell line.
Positive control: No high/medium HPA tissue identified
Negative control: Suggested KO / knockdown lysate
Loading controls: Run GAPDH, β-actin, and a total-protein stain such as Ponceau alongside the samples.
⚠️Feasibility: HPA provides no tissue candidates, so a positive lysate needs independent validation and a knockdown or KO is the practical negative control.

HPA tissue expression evidence for NR0B1

Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.

Higher expression tissues · candidate positive controls from IHC

TissueCell typeLevelEvidenceSource
No high/medium HPA tissues identified in the supplied evidence.

Lower expression tissues · IHC evidence, not confirmed WB-negative controls

TissueCell typeLevelEvidenceSource
No lower-expression tissue rows available in the supplied evidence.
Section 3

Advanced NR0B1 Western Blot Tips

Deeper troubleshooting and optimisation questions for NR0B1, answered from its protein features.

How should NR0B1 band migration be interpreted?
Band shift · Use the separately labelled calculated mass and catalog-observed evidence above. A sequence annotation does not establish an observed migration shift. Verify target identity with orthogonal controls.
How might NR0B1 isoforms affect band interpretation?
Isoforms · UniProt lists two isoforms. In isoform 2, residues 390–400 change from DVPGLQCVKYI to GKGKENDCNHH, and residues 401–470 are missing. These are UniProt coordinates. Isoform 2 could produce a smaller band, but these features alone do not identify the observed 48 kDa band.

Check the antibody epitope against the UniProt sequence changes. An epitope entirely within residues 401–470 of isoform 1 is absent from isoform 2; an epitope spanning residues 390–400 also differs between them.
Could a modification explain an unexpected NR0B1 band?
PTM · The supplied UniProt features list no modified residues or glycosylation sites. Do not assign an unexpected band to a specific modification from this record. The listed isoform sequence changes are another possibility to examine, but they do not establish band identity.
Does this guide establish induction of NR0B1?
Induction · No general induction response is established by this guide. A pathway or gene-set association is not evidence of induction in a particular specimen. Verify the relevant treatment and control in a target-specific experiment.
How should transfer be checked for NR0B1?
Transfer · Standard workflow guidance: verify transfer efficiency for the intended target size before interpreting a weak signal. Use total-protein assessment and optimize transfer for the membrane, gel and apparatus; the labelled catalog values take precedence.
How should blocking be optimized?
Blocking · Standard workflow guidance: follow the A01521-2 datasheet where specified. Otherwise compare 5% milk or 5% BSA in TBST; for a phospho-specific assay start with BSA. Optimize background and specific signal with matched controls.
What matters when quantifying NR0B1 across fractions?
Quantitation · NR0B1 shuttles between nucleus and cytoplasm, so specify whether measurements come from whole-cell lysate or a fraction. For comparisons across fractions, account for fraction loading and recovery before interpreting signal differences as changes in protein abundance.
Why is the observed NR0B1 band below its predicted mass?
Interpretation · The observed band is about 48 kDa, versus a predicted 51.7 kDa for the 470-residue canonical protein. The supplied features do not establish the cause of this difference; confirm band identity before assigning it to an isoform or modification.

NR0B1 is reported in both the nucleus and cytoplasm and shuttles between them. A signal in either fraction is consistent with those locations. Compare fractions when assessing localization; a change in one fraction alone need not reflect a change in total NR0B1.

UniProt reports NR0B1 homodimers and interactions with other proteins. Those interactions make a complex worth considering, but they do not establish that a higher Western blot band contains one. Verify its identity before assigning it to a dimer or binding partner.
Boster reagents

NR0B1 Western Blot Antibodies

Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.

Real WB data Western blot analysis of DAX-1/NR0B1 using anti-DAX-1/NR0B1 antibody (A01521-2). Electrophoresis was performed on a 5-20% SDS-PAGE gel at 70V (Stacking gel) / 90V (Resolving gel) for 2-3 hours. The sample well of each lane was loaded with 30 ug of sample under reducing conditions. Lane 1: human MCF-7 whole cell lysates, Lane 2: human Hela whole cell lysates, Lane 3: human Jurkat whole cell lysates, Lane 4: human U87 whole cell lysates. After electrophoresis, proteins were transferred to a nitrocellulose membrane at 150 mA for 50-90 minutes. Blocked the membrane with 5% non-fat milk/TBS for 1.5 hour at RT. The membrane was incubated with rabbit anti-DAX-1/NR0B1 antigen affinity purified polyclonal antibody (Catalog # A01521-2) at 0.5 μg/mL overnight at 4°C, then washed with TBS-0.1%Tween 3 times with 5 minutes each and probed with a goat anti-rabbit IgG-HRP secondary antibody at a dilution of 1:5000 for 1.5 hour at RT. The signal is developed using an Enhanced Chemiluminescent detection (ECL) kit (Catalog # EK1002) with Tanon 5200 system. A specific band was detected for DAX-1/NR0B1 at approximately 48 kDa. The expected band size for DAX-1/NR0B1 is at 48 kDa.
Anti-DAX-1/NR0B1 Antibody Picoband®
Cat # A01521-2
Real WB data Western blot analysis of NR0B1/DAX1 using anti-NR0B1/DAX1 antibody (M01521). Electrophoresis was performed on a 5-20% SDS-PAGE gel at 70V (Stacking gel) / 90V (Resolving gel) for 2-3 hours. The sample well of each lane was loaded with 30 ug of sample under reducing conditions. Lane 1: human A549 whole cell lysates, Lane 2: human RT4 whole cell lysates. After electrophoresis, proteins were transferred to a nitrocellulose membrane at 150 mA for 50-90 minutes. Blocked the membrane with 5% non-fat milk/TBS for 1.5 hour at RT. The membrane was incubated with rabbit anti-NR0B1/DAX1 antigen affinity purified monoclonal antibody (M01521) at 1:500 overnight at 4°C, then washed with TBS-0.1%Tween 3 times with 5 minutes each and probed with a goat anti-rabbit IgG-HRP secondary antibody at a dilution of 1:500 for 1.5 hour at RT. The signal is developed using an Enhanced Chemiluminescent detection (ECL) kit (Catalog # EK1002) with Tanon 5200 system. A specific band was detected for NR0B1/DAX1 at approximately 48 kDa. The expected band size for NR0B1/DAX1 is at 48 kDa.
Anti-NR0B1 / DAX1 Monoclonal Antibody
Cat # M01521

Both listed anti-NR0B1 antibodies have Western blot images from human cell lysates, with reported bands near the expected 48 kDa. The supplied evidence covers the named lysates and product images; no independent publication evidence is provided.

Which to pick: Choose A01521-2 for its reported WB results in MCF-7, HeLa, Jurkat, or U87 lysates, or M01521 for A549 or RT4 lysates. Both list human reactivity and have WB images; select based on your sample context and preferred polyclonal or monoclonal format.

Source: BosterBio NR0B1 gene-info card — filtered to Western-blot-capable antibodies; each card shows that product's actual WB validation figure.